RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc. financial statements

RegeneRx Biopharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2022

RevenueUSD 76.76KEODHD
Net income−USD 1.73MEODHD
Cash and equivalentsUSD 290.89KEODHD

RegeneRx Biopharmaceuticals, Inc. financials on 6ix · RegeneRx Biopharmaceuticals, Inc. on 6ix